Schonfeld Strategic Advisors’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Buy |
26,200
+700
| +3% | +$763 | ﹤0.01% | 1818 |
|
|
2025
Q1 | $31.9K | Sell |
25,500
-200
| -0.8% | -$250 | ﹤0.01% | 1954 |
|
|
2024
Q4 | $40.3K | Sell |
25,700
-200
| -0.8% | -$314 | ﹤0.01% | 1816 |
|
|
2024
Q3 | $49.5K | Buy |
25,900
+2,200
| +9% | +$4.2K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $46.5K | Buy |
23,700
+200
| +0.9% | +$392 | ﹤0.01% | 1801 |
|
|
2024
Q1 | $55.7K | Buy |
23,500
+300
| +1% | +$711 | ﹤0.01% | 1706 |
|
|
2023
Q4 | $50.1K | Sell |
23,200
-100
| -0.4% | -$216 | ﹤0.01% | 1580 |
|
|
2023
Q3 | $48.9K | Sell |
23,300
-200
| -0.9% | -$420 | ﹤0.01% | 1397 |
|
|
2023
Q2 | $67.2K | Sell |
23,500
-500
| -2% | -$1.43K | ﹤0.01% | 1684 |
|
|
2023
Q1 | $69.8K | Sell |
24,000
-1,200
| -5% | -$3.49K | ﹤0.01% | 1689 |
|
|
2022
Q4 | $73.8K | Buy |
25,200
+400
| +2% | +$1.17K | ﹤0.01% | 2188 |
|
|
2022
Q3 | $60K | Sell |
24,800
-1,400
| -5% | -$3.39K | ﹤0.01% | 2559 |
|
|
2022
Q2 | $59K | Sell |
26,200
-100
| -0.4% | -$225 | ﹤0.01% | 2125 |
|
|
2022
Q1 | $60K | Sell |
26,300
-4,100
| -13% | -$9.35K | ﹤0.01% | 2249 |
|
|
2021
Q4 | $76K | Sell |
30,400
-57,800
| -66% | -$145K | ﹤0.01% | 1845 |
|
|
2021
Q3 | $280K | Buy |
+88,200
| New | +$280K | ﹤0.01% | 1490 |
|